These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 12738755)

  • 1. Foreword.
    Burke GW
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i1-2. PubMed ID: 12738755
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword.
    Vanrenterghem Y
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi1-vi2. PubMed ID: 15575020
    [No Abstract]   [Full Text] [Related]  

  • 3. The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Gritsch HA; Corry RJ; Egidi F; McCauley J; Ellis D; Gilboa N
    Clin Transpl; 1995; ():199-205. PubMed ID: 8794266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and kidney transplantation.
    Curtis J
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):907-8. PubMed ID: 17699305
    [No Abstract]   [Full Text] [Related]  

  • 5. Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences.
    Shrestha BM
    Exp Clin Transplant; 2017 Feb; 15(1):1-9. PubMed ID: 27938316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in kidney transplantation. A clinical review.
    Kliem V; Brunkhorst R
    Nephron; 1998; 79(1):8-20. PubMed ID: 9609456
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance of unresponsiveness by short-term pulse therapy with FK 506 in rat transplantation.
    Hayakawa K; Hata M; Nishiyama T; Ohashi M; Ishikawa M
    Transplant Proc; 1996 Jun; 28(3):1830-1. PubMed ID: 8658904
    [No Abstract]   [Full Text] [Related]  

  • 8. Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil.
    Gomes RM; Guerra Júnior AA; Lemos LL; Costa Jde O; Almeida AM; Alvares J; Filho CS; Cherchiglia ML; Andrade EI; Godman B; Acurcio FA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):991-9. PubMed ID: 27181131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of clonal deletion in immunotolerance induction: tests of Tacrolimus administration in rat renal transplantation.
    Hayakawa K; Hata M; Yanaihara H; Ohashi M; Ishikawa H; Tazaki H
    Transplant Proc; 1994 Aug; 26(4):1863-5. PubMed ID: 7520608
    [No Abstract]   [Full Text] [Related]  

  • 10. FK 506-based immunosuppression in clinical pancreas transplantation.
    Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
    Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
    [No Abstract]   [Full Text] [Related]  

  • 11. Prograf produces more benefits for CYP3A5 low expression patients in early stage after kidney transplantation.
    Fan B; Qiu K; Jiang Y; Hu X; Yin H; Wang W; Ren L; Liu H; Wang W; Zhang X
    Biomed Pharmacother; 2017 Apr; 88():738-744. PubMed ID: 28157649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation.
    Jurewicz WA
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i7-11. PubMed ID: 12738757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring tacrolimus-based immunotherapy in renal transplantation.
    Yang HC
    Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i16-20. PubMed ID: 12738759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies.
    van Hooff JP; Alloway RR; Trunečka P; Mourad M
    Clin Transplant; 2011; 25(1):E1-12. PubMed ID: 21158926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
    Akiyama T; Okazaki H; Takahashi K; Hasegawa A; Tanabe K; Uchida K; Takahara S; Toma H
    Transplant Proc; 2005 Mar; 37(2):843-5. PubMed ID: 15848551
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation.
    Žilinská Z; Dedinská I; Breza J; Laca L
    Transplant Proc; 2016 Oct; 48(8):2637-2643. PubMed ID: 27788794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K
    Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.